当前位置: X-MOL 学术Intensive Care Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Noninvasive respiratory support following extubation in critically ill adults: a systematic review and network meta-analysis
Intensive Care Medicine ( IF 38.9 ) Pub Date : 2021-11-25 , DOI: 10.1007/s00134-021-06581-1
Shannon M Fernando 1, 2 , Alexandre Tran 1, 3, 4 , Behnam Sadeghirad 5, 6 , Karen E A Burns 6, 7, 8 , Eddy Fan 7, 9, 10, 11 , Daniel Brodie 12, 13 , Laveena Munshi 7, 9, 10 , Ewan C Goligher 7, 9, 10, 11 , Deborah J Cook 6, 14 , Robert A Fowler 7, 9, 15 , Margaret S Herridge 7, 9, 10, 11 , Pierre Cardinal 1 , Samir Jaber 16, 17 , Morten Hylander Møller 18 , Arnaud W Thille 19, 20 , Niall D Ferguson 7, 9, 10, 11 , Arthur S Slutsky 7, 8 , Laurent J Brochard 7, 8 , Andrew J E Seely 1, 3, 4, 21 , Bram Rochwerg 6, 14
Affiliation  

Purpose

Systematic review and network meta-analysis to investigate the efficacy of noninvasive respiratory strategies, including noninvasive positive pressure ventilation (NIPPV) and high-flow nasal cannula (HFNC), in reducing extubation failure among critically ill adults.

Methods

We searched databases from inception through October 2021 for randomized controlled trials (RCTs) evaluating noninvasive respiratory support therapies (NIPPV, HFNC, conventional oxygen therapy, or a combination of these) following extubation in critically ill adults. Two reviewers performed screening, full text review, and extraction independently. The primary outcome of interest was reintubation. We used GRADE to rate the certainty of our findings.

Results

We included 36 RCTs (6806 patients). Compared to conventional oxygen therapy, NIPPV (OR 0.65 [95% CI 0.52–0.82]) and HFNC (OR 0.63 [95% CI 0.45–0.87]) reduced reintubation (both moderate certainty). Sensitivity analyses showed that the magnitude of the effect was highest in patients with increased baseline risk of reintubation. As compared to HFNC, no difference in incidence of reintubation was seen with NIPPV (OR 1.04 [95% CI 0.78–1.38], low certainty). Compared to conventional oxygen therapy, neither NIPPV (OR 0.8 [95% CI 0.61–1.04], moderate certainty) or HFNC (OR 0.9 [95% CI 0.66–1.24], low certainty) reduced short-term mortality. Consistent findings were demonstrated across multiple subgroups, including high- and low-risk patients. These results were replicated when evaluating noninvasive strategies for prevention (prophylaxis), but not in rescue (application only after evidence of deterioration) situations.

Conclusions

Our findings suggest that both NIPPV and HFNC reduced reintubation in critically ill adults, compared to conventional oxygen therapy. NIPPV did not reduce incidence of reintubation when compared to HFNC. These findings support the preventative application of noninvasive respiratory support strategies to mitigate extubation failure in critically ill adults, but not in rescue conditions.



中文翻译:

危重成人拔管后的无创呼吸支持:系统评价和网络荟萃分析

目的

系统评价和网络荟萃分析旨在研究无创呼吸策略(包括无创正压通气(NIPPV)和高流量鼻插管(HFNC))在减少危重成人拔管失败方面的功效。

方法

我们检索了从开始到 2021 年 10 月的数据库,以评估危重成人拔管后无创呼吸支持疗法(NIPPV、HFNC、常规氧疗或这些疗法的组合)的随机对照试验 (RCT)。两名审稿人独立进行筛选、全文审阅和提取。感兴趣的主要结果是重新插管。我们使用 GRADE 来评估我们研究结果的确定性。

结果

我们纳入了 36 项随机对照试验(6806 名患者)。与传统氧疗相比,NIPPV(OR 0.65 [95% CI 0.52–0.82])和 HFNC(OR 0.63 [95% CI 0.45–0.87])减少了再插管(均为中等确定性)。敏感性分析显示,基线再插管风险增加的患者的影响程度最高。与 HFNC 相比,NIPPV 的再插管发生率没有差异(OR 1.04 [95% CI 0.78–1.38],低确定性)。与传统氧疗相比,NIPPV(OR 0.8 [95% CI 0.61–1.04],中等确定性)或 HFNC(OR 0.9 [95% CI 0.66–1.24],低确定性)均未降低短期死亡率。多个亚组(包括高风险和低风险患者)的结果一致。这些结果在评估非侵入性预防策略时得到了重复,但在救援(仅在出现恶化证据后应用)情况下没有得到重复。

结论

我们的研究结果表明,与传统氧疗相比,NIPPV 和 HFNC 均减少了危重成人的再插管次数。与 HFNC 相比,NIPPV 并未降低再插管的发生率。这些发现支持预防性应用无创呼吸支持策略来减轻危重成人的拔管失败,但不适用于抢救条件。

更新日期:2022-01-30
down
wechat
bug